Use this instructional guide to review efficacy, dosing, and administration details, and to get information about integrating IMLYGIC® into your practice.
IMLYGIC® is shipped from select authorized specialty distributors—use this guide to find a qualified distributor. Also find information on ordering options, the order and delivery schedule, product storage, and the IMLYGIC® freezer program.
Because of its special properties and storage requirements, IMLYGIC® is shipped on a fixed delivery schedule for coordination with patient scheduling. Download and print a copy of the schedule here for convenience.
Get some key product information, including packaging details, information on ordering IMLYGIC®, and storage and handling requirements.
The Prescribing Information provides all of the requirements for handling IMLYGIC®. This Checklist is not intended to serve as a replacement for the Prescribing Information.
This sheet provides a product overview of IMLYGIC®, including dosing strengths and schedule, administration details, ordering and shipping information, and storage and handling requirements.
The Lesion Tracking Sheet can help you document treatment of melanoma lesions.
Before using IMLYGIC® it is important to review the Prescribing Information. IMLYGIC® requires special storage conditions. Please see the Prescribing Information (section 2) for details on preparation and handling, including guidance on thawing and storage of IMLYGIC® vials.
Orders of IMLYGIC® are managed directly by Amgen. Please complete a Customer Registration Profile at the IMLYGIC® Customer Registration Page to ensure that Amgen has the information needed for processing your orders.
IMPORTANT SAFETY INFORMATION
INDICATION AND LIMITATIONS OF USE
IMLYGIC® is a genetically modified oncolytic viral therapy indicated for the local treatment of unresectable cutaneous, subcutaneous, and nodal lesions in patients with melanoma recurrent after initial surgery.
Limitations of use: IMLYGIC® has not been shown to improve overall survival or have an effect on visceral metastases.